Autologous tumor infiltrating lymphocyte injection（GT201）

BIOLOGICAL2 trials

Sponsors

Grit Biotechnology

Conditions

AdultAdult Gynecological TumorsGynecological Tumors

Early Phase 1

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

TerminatedNCT06834542

Grit BiotechnologyAdult Gynecological Tumors

Start: 2022-11-01End: 2025-12-30Updated: 2026-04-27

Unknown Phase

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)

TerminatedNCT06191900

Grit BiotechnologyAdult, Gynecological Tumors

Start: 2023-06-05End: 2025-12-30Updated: 2026-04-27